Priorities for local immunotherapy research and drug development
Local immunotherapy comprises broad classes of therapeutics that aim to trigger a robust “in situ” immune response that can ultimately generate systemic antitumor immunity. These agents are appealing as resistance to standard immune checkpoint inhibit…